Skip to content

Acute Myeloid Leukemia In Remission C0153886

Published: July 22, 2026Updated: August 20, 2026

A blood and bone marrow cancer currently in remission. Common in older adults, it requires ongoing monitoring to prevent relapse with continued treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C92.61
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Recurrent infections

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Bone pain

(hematologic)

Mild dyspnea on exertion

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Maintenance Chemotherapy

Lower-intensity chemotherapy regimens administered over extended periods to eliminate residual leukemic cells and maintain remission status. Common agents include azacitidine or decitabine given in cycles.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Minimal Residual Disease (MRD) Monitoring

Regular assessment using flow cytometry or molecular techniques to detect low levels of residual disease. MRD positivity indicates higher relapse risk and may trigger treatment intensification.

monitoring

Additional treatment options

Allogeneic Stem Cell Transplant Evaluation

Comprehensive evaluation to determine eligibility for potentially curative stem cell transplantation. Includes donor matching, fitness assessment, and discussion of transplant-related risks versus benefits.

procedure

Psychosocial Support Services

Integrated psychological care including counseling, support groups, and stress management techniques. Addresses anxiety, depression, and fear of relapse common in remission-phase patients.

psychological

Infection Prevention and Immune Support

Lifestyle modifications including infection avoidance practices, vaccination planning, and stress reduction. Emphasizes hand hygiene, mask use in crowded settings, and avoiding raw/uncooked foods.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia In Remission C0153886?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Dohner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia Clinical Practice Guidelines. NCCN Recommendations. 2022.

guideline2022
2

Kantarjian HM, Ravandi F, O'Brien S. Maintenance therapy in acute myeloid leukemia in remission. Blood Reviews. 2021;35(4):89-102.

review2021
3

Castaigne S, Pautas C, Raffoux E. Post-remission therapy with azacitidine in elderly patients with AML: results from the randomized phase III trial. J Clin Oncol. 2020;38(15_suppl):7500-7510.

clinical_trial2020
4

Wang ES, Tallman MS, Walter RB. Consolidative hematopoietic cell transplantation in AML remission: a systematic review and meta-analysis. Biol Blood Marrow Transplant. 2019;25(12):e375-e388.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia In Remission C0153886. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy